The Value of Second-trimester Uterine Artery Doppler Analysis in the Prediction of GDM in a Low- Risk Population
NCT ID: NCT05488197
Last Updated: 2022-08-04
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
700 participants
OBSERVATIONAL
2021-06-10
2022-07-10
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Comparison of the Detection Rates of 50 Gr-100 Gr OGTT and 75 Gr OGTT That Require Medical Treatment of GDM
NCT04585204
Risk Factors and Diagnostic Performance of Predictors as a Screening Technique for Gestational Diabetes Mellitus
NCT06109597
Early Screening of Gestational Diabetes Mellitus and Prospective Cohort Study of Postpartum Follow-up
NCT03825926
Universal Hemoglobin A1c Versus Risk-based Screening for Early Gestational Diabetes Mellitus (EARLY GDM): A Randomized Controlled Trial
NCT06190405
Diagnostic Analysis of Oral Glucose Tolerance Test in Early Pregnancy for Gestational Diabetes Mellitus
NCT05487352
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Group 1 participants with gestational diabetes
uterine artery doppler at 18-23 weeks of pregnancy
uterine artery doppler at 18-23 weeks of pregnancy
Group 2 participants without gestational diabetes
uterine artery doppler at 18-23 weeks of pregnancy
uterine artery doppler at 18-23 weeks of pregnancy
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
uterine artery doppler at 18-23 weeks of pregnancy
uterine artery doppler at 18-23 weeks of pregnancy
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Preeclampsia
* Intrauterine growth restriction
* Chronic Maternal Disease
18 Years
42 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Haseki Training and Research Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Filiz Yarsilikal Guleroglu
Medical Doctor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Haseki Training and Research Hospital
Istanbul, , Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PS-GDM-2022
Identifier Type: OTHER
Identifier Source: secondary_id
PS-GDM-2022
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.